"Black box" warning labels and drug withdrawals

Toxicology and Applied Pharmacology

Volumn 183, Issue 2, 2002, Pages 81-82

  Thomas, John A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAPHYLAXIS; BLOOD DYSCRASIA; BONE MARROW TOXICITY; DRUG APPROVAL; DRUG INDUCED DISEASE; DRUG INDUSTRY; DRUG LABELING; DRUG MARKETING; DRUG PACKAGING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FLANK PAIN; GOVERNMENT; HUMAN; IMMUNOTOXICITY; JAUNDICE; LIVER FAILURE; LIVER TOXICITY; NOTE;

EID: 0036408358     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)99472-X     Document Type: Note

References (4)

1. Beach, J. E., et al. (1998). Food Drug Law 53, 403.
2. Lasser, K. E., et al. (2002). JAMA 287, 2215.
3. Lazarou, J., et al. (1998). JAMA 279, 1200.
4. Wood, A. J. (1999). JAMA 281, 1753.